NAC OSCE Practice Test
NAC OSCE - National Assessment Collaboration NAC OSCE Patient Management & Treatment
According to Diabetes Canada 2023 guidelines, which medication should be added first-line alongside metformin in a patient with type 2 diabetes and established cardiovascular disease?
Select your answer
A
An SGLT2 inhibitor (e.g., empagliflozin) or GLP-1 receptor agonist with proven CV benefit
B
Sulfonylurea (e.g., glyburide)
C
DPP-4 inhibitor (e.g., sitagliptin)
D
Insulin glargine
Hint